Position in LLY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,440,840
+$569,109 QoQ
Shares Held
2,035
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#2,311
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GRANDFIELD & DODD, LLC holds $118,444,709 across 12 Drug Manufacturers - General names. LLY ranks #7 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
106,768 | $27,115,868 | |
| 2 | NVS |
Novartis AG
|
153,436 | $24,046,489 | |
| 3 | MRK |
Merck & Co., Inc.
|
171,554 | $22,044,689 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
154,287 | $19,492,619 | |
| 5 | SNY |
Sanofi
|
384,643 | $16,408,870 | |
| 6 | AMGN |
Amgen Inc
|
7,491 | $2,712,640 | |
| 7 | LLY |
ELI LILLY & Co
This page
|
2,035 | $2,440,840 | |
| 8 | ABBV |
AbbVie Inc.
|
5,744 | $1,445,420 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,440,840 | 2,035 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,871,731 | 2,035 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $2,197,720 | 2,045 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,661,814 | 2,178 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $1,776,548 | 2,279 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,087,900 | 2,528 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $2,064,328 | 2,674 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $2,391,152 | 2,699 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $2,487,984 | 2,748 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,248,304 | 2,890 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $1,725,443 | 2,960 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $1,666,177 | 3,102 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $1,473,066 | 3,141 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,133,629 | 3,301 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $1,207,637 | 3,301 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $944,505 | 2,921 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $947,075 | 2,921 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $879,442 | 3,071 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $848,271 | 3,071 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $709,554 | 3,071 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $704,855 | 3,071 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $552,239 | 2,956 | Shares | Sole | 2021-04-22 | |
| 2020-12-31 | $487,272 | 2,886 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $427,185 | 2,886 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $506,659 | 3,086 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $420,737 | 3,033 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||